State Street’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$90.1K Hold
10,090
﹤0.01% 4045
2025
Q4
$84.1K Hold
10,090
﹤0.01% 4073
2025
Q3
$121K Hold
10,090
﹤0.01% 4017
2025
Q2
$85.6K Hold
10,090
﹤0.01% 4003
2025
Q1
$114K Hold
10,090
﹤0.01% 3946
2024
Q4
$206K Buy
10,090
+590
+6% +$17.2K ﹤0.01% 3846
2024
Q3
$377K Buy
9,500
+1,680
+21% +$45.2K ﹤0.01% 3649
2024
Q2
$138K Buy
7,820
+390
+5% +$6.6K ﹤0.01% 3921
2024
Q1
$123K Hold
7,430
﹤0.01% 3992
2023
Q4
$140K Buy
7,430
+4,070
+121% +$76.5K ﹤0.01% 3971
2023
Q3
$69.9K Hold
3,360
﹤0.01% 4202
2023
Q2
$183K Hold
3,360
﹤0.01% 4031
2023
Q1
$60.8K Buy
3,360
+1,630
+94% +$28.1K ﹤0.01% 4457
2022
Q4
$17.6K Hold
1,730
﹤0.01% 4756
2022
Q3
$23K Hold
1,730
﹤0.01% 4809
2022
Q2
$22K Sell
1,730
-1
-0.1% -$26 ﹤0.01% 4865
2022
Q1
$90K Hold
1,731
﹤0.01% 4672
2021
Q4
$78K Hold
1,731
﹤0.01% 4621
2021
Q3
$113K Hold
1,731
﹤0.01% 4513
2021
Q2
$173K Sell
1,731
-8,326
-83% -$859K ﹤0.01% 4246
2021
Q1
$1.28M Sell
10,057
-867
-8% -$128K ﹤0.01% 3574
2020
Q4
$1.21M Buy
10,924
+3,381
+45% +$379K ﹤0.01% 3524
2020
Q3
$888K Sell
7,543
-331
-4% -$57.3K ﹤0.01% 3471
2020
Q2
$1.69M Sell
7,874
-2,384
-23% -$563K ﹤0.01% 3244
2020
Q1
$2.31M Buy
10,258
+762
+8% +$217K ﹤0.01% 2997
2019
Q4
$2.55M Sell
9,496
-321
-3% -$80.7K ﹤0.01% 3160
2019
Q3
$2.98M Buy
9,817
+681
+7% +$209K ﹤0.01% 3063
2019
Q2
$3.02M Buy
9,136
+686
+8% +$348K ﹤0.01% 3066
2019
Q1
$5.29M Buy
8,450
+256
+3% +$117K ﹤0.01% 2728
2018
Q4
$2.04M Sell
8,194
-333
-4% -$133K ﹤0.01% 3112
2018
Q3
$3.96M Buy
8,527
+226
+3% +$109K ﹤0.01% 2974
2018
Q2
$4.5M Sell
8,301
-7
-0.1% -$4.2K ﹤0.01% 2914
2018
Q1
$4.76M Sell
8,308
-91
-1% -$57.4K ﹤0.01% 2826
2017
Q4
$5.38M Buy
8,399
+242
+3% +$170K ﹤0.01% 2755
2017
Q3
$7.68M Sell
8,157
-53
-0.6% -$40.5K ﹤0.01% 2569
2017
Q2
$7.16M Buy
8,210
+564
+7% +$462K ﹤0.01% 2559
2017
Q1
$5.26M Sell
7,646
-343
-4% -$226K ﹤0.01% 2672
2016
Q4
$5.75M Buy
7,989
+23
+0.3% +$15.9K ﹤0.01% 2613
2016
Q3
$5.87M Buy
7,966
+265
+3% +$215K ﹤0.01% 2470
2016
Q2
$6.41M Sell
7,701
-103
-1% -$95.8K ﹤0.01% 2465
2016
Q1
$6.45M Buy
7,804
+302
+4% +$237K ﹤0.01% 2414
2015
Q4
$8.45M Buy
7,502
+29
+0.4% +$33.7K ﹤0.01% 2283
2015
Q3
$6.34M Buy
7,473
+421
+6% +$610K ﹤0.01% 2409
2015
Q2
$12.5M Buy
7,052
+37
+0.5% +$47K ﹤0.01% 2148
2015
Q1
$8.43M Buy
7,015
+754
+12% +$883K ﹤0.01% 2301
2014
Q4
$7.08M Buy
6,261
+355
+6% +$364K ﹤0.01% 2385
2014
Q3
$5.94M Sell
5,906
-31
-0.5% -$35K ﹤0.01% 2458
2014
Q2
$7.83M Sell
5,937
-157
-3% -$189K ﹤0.01% 2351
2014
Q1
$8.49M Buy
6,094
+204
+3% +$265K ﹤0.01% 2291
2013
Q4
$6.76M Buy
5,890
+432
+8% +$596K ﹤0.01% 2408
2013
Q3
$6.85M Buy
5,458
+251
+5% +$170K ﹤0.01% 2338
2013
Q2
$2.07M Buy
+5,207
New +$2.21M ﹤0.01% 2970

Other funds holding RMTI

State Street's RMTI Position: Q1 2026 in Review

State Street held its Rockwell Medical (RMTI) position steady in Q1 2026 at 10,090 shares worth $90.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4045.

State Street first reported a position in RMTI in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.5M in Q2 2015. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.

  • State Street held 10,090 shares of Rockwell Medical worth $90.1K as of Q1 2026.
  • State Street left its Rockwell Medical share count unchanged in Q1 2026.
  • Rockwell Medical made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4045 holding.
  • State Street first reported a position in Rockwell Medical in Q2 2013 and has held it in 52 quarters since.
  • State Street's Rockwell Medical position peaked at $12.5M in Q2 2015.
  • 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.